These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 36509982)

  • 21. Investigating Functional Network Abnormalities and Associations With Disability in Multiple Sclerosis.
    Carotenuto A; Valsasina P; Schoonheim MM; Geurts JJG; Barkhof F; Gallo A; Tedeschi G; Tommasin S; Pantano P; Filippi M; Rocca MA;
    Neurology; 2022 Nov; 99(22):e2517-e2530. PubMed ID: 36096690
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determinants of Deep Gray Matter Atrophy in Multiple Sclerosis: A Multimodal MRI Study.
    Pontillo G; Cocozza S; Lanzillo R; Russo C; Stasi MD; Paolella C; Vola EA; Criscuolo C; Borrelli P; Palma G; Tedeschi E; Morra VB; Elefante A; Brunetti A
    AJNR Am J Neuroradiol; 2019 Jan; 40(1):99-106. PubMed ID: 30573464
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Abnormal functional connectivity and cortical integrity influence dominant hand motor disability in multiple sclerosis: a multimodal analysis.
    Zhong J; Nantes JC; Holmes SA; Gallant S; Narayanan S; Koski L
    Hum Brain Mapp; 2016 Dec; 37(12):4262-4275. PubMed ID: 27381089
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dynamic gray matter volume changes in pediatric multiple sclerosis: A 3.5 year MRI study.
    De Meo E; Meani A; Moiola L; Ghezzi A; Veggiotti P; Filippi M; Rocca MA
    Neurology; 2019 Apr; 92(15):e1709-e1723. PubMed ID: 30867274
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Age-dependent cut-offs for pathological deep gray matter and thalamic volume loss using Jacobian integration.
    Opfer R; Krüger J; Spies L; Hamann M; Wicki CA; Kitzler HH; Gocke C; Silva D; Schippling S
    Neuroimage Clin; 2020; 28():102478. PubMed ID: 33269702
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of an individual 12-week community-located "start-to-run" program on physical capacity, walking, fatigue, cognitive function, brain volumes, and structures in persons with multiple sclerosis.
    Feys P; Moumdjian L; Van Halewyck F; Wens I; Eijnde BO; Van Wijmeersch B; Popescu V; Van Asch P
    Mult Scler; 2019 Jan; 25(1):92-103. PubMed ID: 29113572
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Impact of Intracortical Lesions on Volumes of Subcortical Structures in Multiple Sclerosis.
    Kalinin I; Makshakov G; Evdoshenko E
    AJNR Am J Neuroradiol; 2020 May; 41(5):804-808. PubMed ID: 32381540
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of aerobic exercise on clinical and magnetic resonance imaging biomarkers in persons with multiple sclerosis: An exploratory randomized controlled trial.
    Savšek L; Stergar T; Strojnik V; Ihan A; Koren A; Špiclin Ž; Šega Jazbec S
    J Rehabil Med; 2021 Apr; 53(4):jrm00178. PubMed ID: 33739437
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cortical lesions and atrophy associated with cognitive impairment in relapsing-remitting multiple sclerosis.
    Calabrese M; Agosta F; Rinaldi F; Mattisi I; Grossi P; Favaretto A; Atzori M; Bernardi V; Barachino L; Rinaldi L; Perini P; Gallo P; Filippi M
    Arch Neurol; 2009 Sep; 66(9):1144-50. PubMed ID: 19752305
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cortical atrophy patterns in multiple sclerosis are non-random and clinically relevant.
    Steenwijk MD; Geurts JJ; Daams M; Tijms BM; Wink AM; Balk LJ; Tewarie PK; Uitdehaag BM; Barkhof F; Vrenken H; Pouwels PJ
    Brain; 2016 Jan; 139(Pt 1):115-26. PubMed ID: 26637488
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of Cortical and Deep Gray Matter Lesions in Multiple Sclerosis Using DIR and FLAIR at 3T.
    Park CC; Thongkham DW; Sadigh G; Saindane AM; Chu R; Bakshi R; Allen JW; Hu R
    J Neuroimaging; 2021 Mar; 31(2):408-414. PubMed ID: 33351983
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multicenter data harmonization for regional brain atrophy and application in multiple sclerosis.
    Pagani E; Storelli L; Pantano P; Petsas N; Tedeschi G; Gallo A; De Stefano N; Battaglini M; Rocca MA; Filippi M;
    J Neurol; 2023 Jan; 270(1):446-459. PubMed ID: 36152049
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regional Distribution and Evolution of Gray Matter Damage in Different Populations of Multiple Sclerosis Patients.
    Calabrese M; Reynolds R; Magliozzi R; Castellaro M; Morra A; Scalfari A; Farina G; Romualdi C; Gajofatto A; Pitteri M; Benedetti MD; Monaco S
    PLoS One; 2015; 10(8):e0135428. PubMed ID: 26267665
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lower self-report fatigue in multiple sclerosis is associated with localized white matter tract disruption between amygdala, temporal pole, insula, and other connected structures.
    Fuchs TA; Vaughn CB; Benedict RHB; Weinstock-Guttman B; Choudhery S; Carolus K; Rooney P; Ashton K; P Ramasamy D; Jakimovski D; Zivadinov R; Dwyer MG
    Mult Scler Relat Disord; 2019 Jan; 27():298-304. PubMed ID: 30453198
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of the genetic contribution to brain magnetic resonance imaging lesion load and atrophy measures in multiple sclerosis patients.
    Clarelli F; Assunta Rocca M; Santoro S; De Meo E; Ferrè L; Sorosina M; Martinelli Boneschi F; Esposito F; Filippi M
    Eur J Neurol; 2021 Aug; 28(8):2513-2522. PubMed ID: 33864731
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of disease-modifying therapies on subcortical gray matter atrophy in multiple sclerosis.
    Sotirchos ES; Gonzalez-Caldito N; Dewey BE; Fitzgerald KC; Glaister J; Filippatou A; Ogbuokiri E; Feldman S; Kwakyi O; Risher H; Crainiceanu C; Pham DL; Van Zijl PC; Mowry EM; Reich DS; Prince JL; Calabresi PA; Saidha S
    Mult Scler; 2020 Mar; 26(3):312-321. PubMed ID: 30741108
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patterns of cortical grey matter thickness reduction in multiple sclerosis.
    Fujimori J; Fujihara K; Wattjes M; Nakashima I
    Brain Behav; 2021 Apr; 11(4):e02050. PubMed ID: 33506628
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A clinically feasible 7-Tesla protocol for the identification of cortical lesions in Multiple Sclerosis.
    Cocozza S; Cosottini M; Signori A; Fleysher L; El Mendili MM; Lublin F; Inglese M; Roccatagliata L
    Eur Radiol; 2020 Aug; 30(8):4586-4594. PubMed ID: 32211962
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-resolution T1-relaxation time mapping displays subtle, clinically relevant, gray matter damage in long-standing multiple sclerosis.
    Steenwijk MD; Vrenken H; Jonkman LE; Daams M; Geurts JJ; Barkhof F; Pouwels PJ
    Mult Scler; 2016 Sep; 22(10):1279-88. PubMed ID: 26564997
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Are Cerebral Perfusion and Atrophy Linked in Multiple Sclerosis? Evidence for a Multifactorial Approach to Assess Neurodegeneration.
    Laganá MM; Mendozzi L; Pelizzari L; Bergsland NP; Pugnetti L; Cecconi P; Baselli G; Clerici M; Nemni R; Baglio F
    Curr Neurovasc Res; 2018; 15(4):282-291. PubMed ID: 30468125
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.